Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab

Bibliographic Details
Main Authors:	Udo Schneider, Jens Nee, Lennard Ostendorf, Frédéric Muench, Lena Thormählen, Zaza Galbavý, Roland Körner
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/9/3/e003238.full

Similar Items

Daratumumab for autoimmune diseases: a systematic review
by: Martin Krusche, et al.
Published: (2023-11-01)

Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
by: Torben Plesner
Published: (2021-03-01)

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients
by: Kristine A. Frerichs, et al.
Published: (2021-05-01)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
by: Ilaria Saltarella, et al.
Published: (2020-01-01)

Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma
by: Aimaz Afrough, et al.
Published: (2023-10-01)

Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis
by: Spyridon Lipka, et al.
Published: (2023-01-01)

Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis.
by: Spyridon Lipka, et al.
Published: (2023-01-01)

DARATUMUMAB FOR THE TREATMENT OF MULTIPLE MYELOMA
by: V. V. Ryzhko, et al.
Published: (2017-11-01)

COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report
by: Karolina Anderle, et al.
Published: (2022-07-01)

HFOV in inhalational injury associated ARDS with broncho-pleural fistula – An old friend to the rescue: Case report
by: Ravi Ranjan, et al.
Published: (2023-04-01)

Delivery decision in pregnant women rescued by ECMO for severe ARDS: a retrospective multicenter cohort study
by: Sarah Aissi James, et al.
Published: (2022-10-01)

Daratumumab: A drug with transfusion dilemma
by: Amit Kumar Biswas, et al.
Published: (2023-01-01)

Daratumumab-induced transient myopic shift
by: Maria A. Mavrommatis, et al.
Published: (2019-03-01)

Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies
by: Anaïs Nombel, et al.
Published: (2022-11-01)

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
by: Maria Gavriatopoulou, et al.
Published: (2020-06-01)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
by: Giovanni Palladini, et al.
Published: (2021-03-01)

Efficacy of daratumumab in refractory primary Sjögren disease
by: Xavier Mariette, et al.
Published: (2023-07-01)

SAFETY OF DARATUMUMAB IN FRAIL PATIENTS WITH MULTIPLE MYELOMA
by: TX Carneiro, et al.
Published: (2023-10-01)

Blood group-specific apheresis in combination with daratumumab as a rescue therapy of acute antibody-mediated rejection in a case of ABO- and human leukocyte antigen-incompatible kidney transplantation
by: Can C Süsal, et al.
Published: (2023-11-01)

Corticosteroids in ARDS
by: Emmanuelle Kuperminc, et al.
Published: (2023-05-01)

Daratumumab Treatment for “Truly Frail” Elderly Myeloma Patients
by: Yuichi Horigome, et al.
Published: (2024-03-01)

Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma
by: Marina Zajec, et al.
Published: (2020-08-01)

Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
by: Hughes MS, et al.
Published: (2023-12-01)

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
by: Jahanzaib Khwaja, et al.
Published: (2022-08-01)

Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA)
by: Barrett, Christopher D
Published: (2020)

Early vvECMO implantation may be associated with lower mortality in ARDS
by: Peter Rosenberger, et al.
Published: (2023-09-01)

Neuropilin-1 Knockout and Rescue Confirms Its Role to Promote Metastasis in MDA-MB-231 Breast Cancer Cells
by: Noura Al-Zeheimi, et al.
Published: (2023-04-01)

Anti cancer activity of plant extracts on MDA-MB231
by: Yussoff, Seri Wahyuni
Published: (2015)

Clinical Images: Cutaneous ulcerations in anti‐MDA‐5 dermatomyositis
by: Eaman Alhassan, et al.
Published: (2024-03-01)

How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
by: Sami Hraiech, et al.
Published: (2017-08-01)

P930: ELRANATAMAB MONOTHERAPY OR IN COMBINATION WITH DARATUMUMAB VS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: PHASE 3 MAGNETISMM-5 STUDY, PART 2
by: Xavier Leleu, et al.
Published: (2023-08-01)

Time in (Ard-Alkarab)
by: Adnan Kalid
Published: (1985-12-01)

Cardiovascular Subphenotypes in ARDS: Diagnostic and Therapeutic Implications and Overlap with Other ARDS Subphenotypes
by: Minesh Chotalia, et al.
Published: (2023-05-01)

Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis
by: Yan Wang, et al.
Published: (2023-08-01)

CD56 expression predicts response to Daratumumab-based regimens
by: Allen J. Robinette, et al.
Published: (2024-04-01)

Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
by: Irene Zamanillo, et al.
Published: (2023-08-01)

Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
by: Cristina Gasparetto, et al.
Published: (2021-02-01)

Anti⁃CD38 monoclonal antibody daratumumab treatment in severe anti⁃N ⁃methyl⁃D ⁃aspartate receptor encephalitis: one case report
by: ZHANG Chao, et al.
Published: (2023-12-01)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
by: Uroosa Ibrahim, et al.
Published: (2023-10-01)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)